Brief: Cross Country Healthcare Q3 Adjusted EPS USD 0.12 Vs. IBES Estimate USD 0.1
06/11/2024 21:15
Nov 06 (Reuters) - Cross Country Healthcare Q3 adjusted EBITDA USD 10.339 million vs. IBES estimate USD 11.5 million. * Q3 gross margin 20.4% * Q3 EPS USD 0.08 * Q3 net income USD 2.555 million * Q3 revenue USD 315.119 million vs. IBES estimate USD 310.2 million * Q3 adjusted EBITDA margin 3.3%
Recent news on Cross Country Healthcare
See all newsNASDAQ TRADE HALT CONTINUES REASON NOT AVAILABLE AT 03:58 AM
NASDAQ TRADE HALT TRADING HALTED; FOR INFORMATION REQUESTED BY NASDAQ AT 07:50 PM
Cross Country Healthcare Q1 revenue falls 18% but beats estimates
Brief: Cross Country Healthcare Q1 Adjusted EPS USD -0.03 Vs. IBES Estimate USD -0.04
Brief: Cross Country Healthcare To Be Acquired By Knox Lane In All-Cash Transaction Valued At $437 Million